Core Laboratories Inc. /DE/
Core Laboratories Inc. /DE/
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 23 | 23 | 23 | 26 | 31 | 22 | 19 | 21 | 18 | 15 | 15 | 17 | |||||
Accounts Receivable Net Current | 109 | 108 | 114 | 110 | 114 | 117 | 112 | 118 | 116 | 115 | 109 | 104 | |||||
Inventory Net | 58 | 58 | 54 | 58 | 60 | 59 | 59 | 65 | 70 | 71 | 72 | 75 | |||||
Assets Current | |||||||||||||||||
Assets Current | 214 | 214 | 215 | 227 | 238 | 229 | 221 | 235 | 234 | 229 | 223 | 229 | |||||
Prepaid Expense Current | 11 | 11 | 10 | 10 | 11 | 10 | 10 | 10 | 10 | 10 | 8 | 11 | |||||
Income Taxes Receivable | 7 | 7 | 7 | 15 | 14 | 14 | 10 | 15 | 15 | 14 | 14 | 17 | |||||
Other Assets Current | 7 | 7 | 7 | 8 | 8 | 6 | 11 | 6 | 5 | 4 | 5 | 5 | |||||
Property Plant And Equipment Net | 100 | 100 | 99 | 98 | 98 | 98 | 97 | 98 | 99 | 99 | 100 | 99 | |||||
Operating Lease Right Of Use Asset | 53 | 55 | 54 | 54 | 55 | 57 | 56 | 57 | 56 | 54 | 54 | 53 | |||||
Intangible Assets Net Excluding Goodwill | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | |||||
Goodwill | 106 | 106 | 106 | 100 | 100 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | |||||
Deferred Income Tax Assets Net | 71 | 71 | 67 | 71 | 70 | 68 | 70 | 70 | 71 | 66 | 69 | 72 | |||||
Other Assets Noncurrent | 36 | 35 | 35 | 36 | 35 | 34 | 35 | 35 | 33 | 34 | 34 | 32 | |||||
Assets | 587 | 588 | 584 | 591 | 597 | 586 | 585 | 600 | 598 | 588 | 586 | 592 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 40 | 40 | 37 | 37 | 42 | 38 | 35 | 34 | 37 | 32 | 34 | 34 | |||||
Employee Related Liabilities Current | 22 | 22 | 27 | 23 | 25 | 24 | 23 | 22 | 22 | 20 | 19 | 19 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 101 | 105 | 106 | 96 | 105 | 104 | 102 | 95 | 98 | 85 | 88 | 84 | |||||
Operating Lease Liability Current | 12 | 12 | 11 | 11 | 12 | 12 | 11 | 11 | 11 | 10 | 10 | 10 | |||||
Taxes Payable Current | 2 | 4 | 4 | 4 | 4 | 5 | 10 | 5 | 8 | 4 | 7 | 5 | |||||
Other Accrued Liabilities Current | 17 | 17 | 17 | 9 | 9 | 10 | 8 | 9 | 9 | 9 | 8 | 9 | |||||
Long Term Debt And Capital Lease Obligations | 114 | 114 | 110 | 114 | 125 | 124 | 126 | 140 | 148 | 160 | 163 | 178 | |||||
Operating Lease Liability Noncurrent | 39 | 41 | 42 | 42 | 42 | 44 | 43 | 44 | 43 | 41 | 42 | 41 | |||||
Deferred Compensation Liability Classified Noncurr… | 30 | 28 | 29 | 31 | 30 | 29 | 31 | 32 | 31 | 30 | 31 | 29 | |||||
Deferred Income Tax Liabilities Net | 8 | 8 | 8 | 10 | 11 | 10 | 9 | 14 | 13 | 13 | 13 | 12 | |||||
Other Liabilities Noncurrent | 16 | 16 | 16 | 21 | 22 | 21 | 21 | 20 | 20 | 20 | 20 | 19 | |||||
Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 116 | 115 | 110 | 114 | 113 | 114 | 110 | 113 | 113 | 115 | 110 | 109 | |||||
Retained Earnings Accumulated Deficit | 177 | 171 | 173 | 174 | 160 | 150 | 145 | 143 | 132 | 124 | 121 | 119 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -5 | -5 | -5 | -5 | -4 | |||||
Treasury Stock Value | -15 | -12 | -12 | -11 | -6 | -4 | -3 | -0 | -0 | -1 | -1 | -0 | |||||
Stockholders Equity | 279 | 275 | 266 | 271 | 262 | 254 | 247 | 251 | 246 | 237 | 230 | 225 | |||||
Minority Interest | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | |||||
Liabilities And Stockholders Equity | 587 | 588 | 584 | 591 | 602 | 592 | 585 | 600 | 598 | 588 | 586 | 592 | |||||
Allowance For Doubtful Accounts Receivable Current | 7 | 6 | 6 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 2 | 2 | |||||
Accumulated Depreciation Depletion And Amortizatio… | 319 | 319 | 321 | 321 | 319 | 317 | 314 | 319 | 318 | 318 | 316 | 319 | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | 20 | 20 | 20 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 18 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Common Stock Shares Issued | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | |||||
Shares Outstanding | 46 | 46 | 46 | 46 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | |||||
Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.14% | -16.85% | -19.34% | - | - | - | - | - | - | - | - | - |
| 2025 | -3.90% | 9.91% | 0.97% | -10.91% | 5.64% | -11.85% | -6.39% | 0.25% | 15.39% | -2.19% | -22.47% | -21.93% |
| 2024 | 5.75% | 4.99% | 27.67% | -19.92% | -30.15% | -20.66% | 3.17% | 2.69% | -4.91% | -14.61% | -30.88% | -29.04% |
| 2023 | - | - | - | - | - | - | -12.85% | -14.45% | -27.40% | 7.20% | 16.54% | 7.13% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.12 | 2.05 | 2.02 | 2.37 | 2.27 | 2.21 | 2.16 | 2.48 | 2.39 | 2.68 | 2.53 | 2.71 | |||||
| Quick Ratio | 1.44 | 1.39 | 1.42 | 1.66 | 1.60 | 1.54 | 1.48 | 1.69 | 1.58 | 1.74 | 1.63 | 1.69 | |||||
| Working Capital | 113.31M | 109.64M | 108.65M | 131.17M | 132.91M | 125.04M | 118.89M | 140.29M | 135.93M | 143.58M | 135.04M | 144.29M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.36 | 0.38 | 0.39 | 0.35 | 0.40 | 0.41 | 0.41 | 0.37 | 0.40 | 0.36 | 0.38 | 0.37 | |||||
| Interest Coverage TTM | 4.35 | 4.97 | 5.34 | 5.17 | 4.86 | 4.71 | 4.73 | 3.90 | 3.58 | 3.75 | - | - | |||||
| Debt Ratio | 0.17 | 0.18 | 0.18 | 0.16 | 0.18 | 0.18 | 0.18 | 0.16 | 0.16 | 0.15 | 0.15 | 0.14 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.88 | 0.89 | 0.90 | 0.87 | 0.87 | 0.88 | 0.89 | 1.09 | 1.07 | 1.09 | - | - | |||||
| Days Sales Outstanding TTM | 78.29 | 78.36 | 78.09 | 80.35 | 80.97 | 81.81 | 77.03 | 62.12 | 63.23 | 65.70 | - | - | |||||
| Receivables Turnover TTM | 4.66 | 4.66 | 4.67 | 4.54 | 4.51 | 4.46 | 4.74 | 5.88 | 5.77 | 5.56 | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.53 | 0.64 | 0.65 | 0.70 | 0.65 | 0.62 | 0.67 | 0.60 | 0.55 | 0.84 | - | - | |||||
| Free Cash Flow Per Share TTM | 0.33 | 0.49 | 0.56 | 0.83 | 0.90 | 0.98 | 0.95 | 0.93 | 0.63 | 0.36 | - | - | |||||
| Dividend Per Share TTM | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | - | - | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 40.86% | 41.81% | 42.60% | 42.98% | 42.85% | 42.75% | 43.24% | 43.76% | 43.98% | 44.33% | - | - | |||||
| Operating Profit Margin TTM | 9.21% | 10.28% | 10.72% | 10.59% | 10.38% | 10.51% | 11.18% | 10.05% | 9.39% | 9.89% | - | - | |||||
| Net Profit Margin TTM | 4.76% | 5.63% | 5.77% | 6.40% | 5.92% | 5.60% | 6.14% | 4.44% | 4.12% | 6.29% | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 0.35% | 1.34% | 0.51% | -20.53% | -19.43% | -19.02% | - | - | - | - | - | - | |||||
| Net Income Growth (1Y) | -19.31% | 1.83% | -5.48% | 14.46% | 15.80% | -27.94% | - | - | - | - | - | - | |||||
| EPS Growth (1Y) | -18.26% | 3.38% | -4.52% | 16.09% | 16.48% | -27.80% | - | - | - | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 21.70 | 26.15 | 24.43 | 17.23 | 17.49 | 24.06 | 25.12 | 29.89 | 35.79 | 19.75 | - | - | |||||
| P/B TTM | 1.92 | 2.81 | 2.73 | 2.06 | 2.04 | 2.75 | 3.20 | 3.37 | 3.85 | 3.35 | 3.56 | 4.85 | |||||
| P/S TTM | 1.03 | 1.47 | 1.41 | 1.10 | 1.03 | 1.35 | 1.54 | 1.33 | 1.47 | 1.24 | - | - | |||||
| Market Cap | 535.78M | 772.30M | 742.59M | 570.20M | 535.18M | 697.92M | 807.59M | 864.51M | 945.90M | 794.91M | 818.27M | 1.11B | |||||
| Enterprise Value | 626.90M | 863.94M | 830.15M | 658.67M | 628.60M | 800.18M | 914.54M | 982.91M | 1.08B | 940.37M | 966.28M | 1.27B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 15.14M | 22.46M | 25.82M | 38.19M | 42.07M | 45.90M | 44.50M | 43.82M | 29.78M | 16.69M | - | - | |||||
| Net Debt | 91.13M | 91.64M | 87.55M | 88.47M | 93.43M | 102.26M | 106.95M | 118.40M | 129.93M | 145.46M | 148.01M | 161.25M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Core Laboratories Inc. /DE/ (CLB) — SEC Financial Statements & Analysis
Core Laboratories Inc. /DE/ (CLB) is a oil & gas field services, nec company, incorporated in DE. Core Laboratories Inc. /DE/ trades on NYSE as: CLB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Core Laboratories Inc. /DE/ reported a 0.35% year-over-year revenue growth, a Gross Profit Margin of 40.86% (TTM), a Debt-to-Equity ratio of 0.36x, a Price-to-Sales (P/S) ratio of 1.03x (TTM), a Price-to-Book (P/B) ratio of 1.92x (TTM), at a market cap of $535.78M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 0.35%
- Gross Profit Margin TTM
- 40.86%
- Debt To Equity
- 0.36x
- P/S TTM
- 1.03x
- P/B TTM
- 1.92x
- Market Cap
- $535.78M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Core Laboratories Inc. /DE/ in?
Core Laboratories Inc. /DE/ (CLB) operates in the Oil & Gas Field Services, NEC industry.
What is CLB's market cap?
Core Laboratories Inc. /DE/ (CLB) has a market capitalization of $535.78M as of 2026-06-30.
What is CLB's P/E ratio?
Core Laboratories Inc. /DE/ (CLB)'s trailing twelve month P/E ratio is 21.70x as of 2026-06-30.
What exchange does CLB trade on?
Core Laboratories Inc. /DE/ (CLB) trades on the NYSE.
Where is Core Laboratories Inc. /DE/ incorporated?
Core Laboratories Inc. /DE/ is incorporated in DE.